Datasets

HealthData.Gov

Omapatrilat normalizes renal function curve in spontaneously hypertensive rats

Background The present study was designed to analyze the chronic renal response to omapatrilat, a new vasopeptidase inhibitor, in spontaneously hypertensive rats (SHR). To that end, the renal and blood pressure response…